Progressive atrioventricular conduction block in a mouse myotonic dystrophy model.

Area of Science:

• Cardiovascular Research
• Genetics
• Neuromuscular Disorders

Background:

• Myotonic dystrophy, caused by CTG repeat expansion on chromosome 19, results in myopathy and cardiac conduction issues.
• A mouse model with targeted disruption of the myotonic dystrophy protein kinase (DMPK) gene mimics human cardiac phenotypes.
• DMPK-deficient mice show abnormalities in atrioventricular (A-V) conduction.

Purpose of the Study:

• To investigate the age-related progression of atrioventricular block in a mouse model of DMPK deficiency.
• To understand the role of DMPK gene dosage in cardiac conduction defects.

Main Methods:

• Surface ECGs and intracardiac electrophysiology studies were conducted on immature and adult mice with varying DMPK gene status (homozygous, heterozygous, wild-type).
• Key ECG intervals (RR, PR, QRS, QT) and electrophysiological parameters (sinus node recovery time, A-V refractory periods, block cycle lengths) were analyzed.
• Comparisons were made between different genotypes and age groups.

Main Results:

• No significant differences in ECG or EP findings were observed in young mutant mice.
• Progressive PR interval prolongation was noted in older mutant mice.
• Adult DMPK-/- mice developed varying degrees of A-V block (1st, 2nd, 3rd degree), while DMPK+/- mice showed only 1st-degree A-V block, indicating gene dosage sensitivity.

Conclusions:

• Cardiac conduction in myotonic dystrophy is influenced by both the animal's age and the DMPK gene dose.
• This mouse model accurately reflects the human phenotype, including age-related progression of atrioventricular conduction defects.